1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Endometrial cancers

Dostarlimab with platinum-based chemotherapy for advanced or recurrent endometrial cancer with microsatellite stability or mismatch repair proficiency ID6415

In development [GID-TA11503] Expected publication date: 10 September 2025

  • Project information
  • Project documents

NIHRIO BN: 37641-Dostarlimab-Paclitaxel-Carboplatin-for-Endometrial-Cancer-V1.0-DEC2023-NON-CONF.pdf (nihr.ac.uk)